 Jeffrey Kavanaugh
Concepts (238)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Staphylococcus aureus | 14 | 2026 | 460 | 2.230 |
Why?
| | Quorum Sensing | 13 | 2026 | 79 | 1.980 |
Why?
| | Staphylococcal Infections | 11 | 2022 | 390 | 1.540 |
Why?
| | Bacterial Proteins | 16 | 2026 | 962 | 1.430 |
Why?
| | Biofilms | 9 | 2022 | 278 | 1.390 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 12 | 2026 | 249 | 1.250 |
Why?
| | Lipoproteins | 3 | 2024 | 169 | 0.900 |
Why?
| | Hemoglobins | 7 | 2005 | 384 | 0.740 |
Why?
| | Neutrophils | 3 | 2024 | 1134 | 0.700 |
Why?
| | Cathepsin G | 1 | 2021 | 4 | 0.690 |
Why?
| | Phagocytosis | 1 | 2021 | 299 | 0.600 |
Why?
| | Peptides, Cyclic | 6 | 2019 | 275 | 0.500 |
Why?
| | Hemoglobin A | 6 | 1999 | 21 | 0.490 |
Why?
| | Homoserine | 2 | 2013 | 6 | 0.460 |
Why?
| | Yersinia pestis | 2 | 2013 | 45 | 0.440 |
Why?
| | Hemoglobins, Abnormal | 4 | 2005 | 8 | 0.440 |
Why?
| | Lactones | 2 | 2013 | 58 | 0.440 |
Why?
| | Staphylococcal Skin Infections | 4 | 2026 | 43 | 0.430 |
Why?
| | Environment | 1 | 2016 | 305 | 0.420 |
Why?
| | Virulence | 8 | 2026 | 280 | 0.400 |
Why?
| | Gene Expression Regulation, Bacterial | 6 | 2026 | 328 | 0.360 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 1500 | 0.350 |
Why?
| | Skin | 4 | 2026 | 758 | 0.320 |
Why?
| | Protein Subunits | 4 | 2005 | 226 | 0.310 |
Why?
| | Mass Spectrometry | 4 | 2019 | 750 | 0.290 |
Why?
| | Carrier Proteins | 1 | 2011 | 737 | 0.260 |
Why?
| | Anti-Bacterial Agents | 7 | 2022 | 1915 | 0.260 |
Why?
| | Protein Conformation | 6 | 2004 | 946 | 0.250 |
Why?
| | Tyrosine | 2 | 2005 | 222 | 0.250 |
Why?
| | Globins | 2 | 2005 | 21 | 0.250 |
Why?
| | Protein Structure, Tertiary | 4 | 2011 | 862 | 0.250 |
Why?
| | Serine Endopeptidases | 1 | 2007 | 128 | 0.240 |
Why?
| | Models, Molecular | 11 | 2016 | 1619 | 0.240 |
Why?
| | Wound Infection | 1 | 2026 | 57 | 0.230 |
Why?
| | Mutation | 9 | 2026 | 4099 | 0.230 |
Why?
| | Virulence Factors | 5 | 2026 | 174 | 0.220 |
Why?
| | Crystallography, X-Ray | 8 | 2005 | 493 | 0.220 |
Why?
| | Trans-Activators | 5 | 2026 | 405 | 0.220 |
Why?
| | Streptococcus agalactiae | 1 | 2026 | 109 | 0.210 |
Why?
| | Diabetes Complications | 1 | 2026 | 223 | 0.210 |
Why?
| | Androgens | 1 | 2026 | 186 | 0.210 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2024 | 40 | 0.210 |
Why?
| | Cell Membrane | 3 | 2021 | 706 | 0.200 |
Why?
| | Streptococcal Infections | 1 | 2026 | 169 | 0.200 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2024 | 266 | 0.200 |
Why?
| | Amino Acid Substitution | 2 | 2001 | 304 | 0.190 |
Why?
| | Staphylococcus epidermidis | 2 | 2020 | 79 | 0.180 |
Why?
| | Micrococcal Nuclease | 2 | 2013 | 26 | 0.180 |
Why?
| | Cephalexin | 1 | 2022 | 14 | 0.180 |
Why?
| | Membrane Proteins | 2 | 2013 | 1167 | 0.180 |
Why?
| | Testosterone | 1 | 2026 | 419 | 0.180 |
Why?
| | Pneumonia, Bacterial | 1 | 2022 | 113 | 0.170 |
Why?
| | Tryptophan | 2 | 2005 | 181 | 0.170 |
Why?
| | DNA, Bacterial | 2 | 2020 | 342 | 0.170 |
Why?
| | Coinfection | 1 | 2022 | 141 | 0.170 |
Why?
| | Extracellular Traps | 1 | 2021 | 57 | 0.170 |
Why?
| | Protein Structure, Quaternary | 4 | 2005 | 116 | 0.170 |
Why?
| | Binding Sites | 4 | 2011 | 1331 | 0.170 |
Why?
| | Cysteine Proteases | 1 | 2020 | 8 | 0.160 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2001 | 381 | 0.160 |
Why?
| | Molecular Sequence Data | 5 | 2011 | 2931 | 0.150 |
Why?
| | Blotting, Southwestern | 1 | 2019 | 2 | 0.150 |
Why?
| | Microbial Sensitivity Tests | 5 | 2022 | 371 | 0.150 |
Why?
| | Static Electricity | 1 | 2019 | 113 | 0.150 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2019 | 81 | 0.150 |
Why?
| | Mice | 13 | 2026 | 18365 | 0.140 |
Why?
| | Plant Extracts | 3 | 2017 | 187 | 0.130 |
Why?
| | Protein Kinases | 2 | 2026 | 315 | 0.130 |
Why?
| | Amino Acid Sequence | 3 | 2011 | 2157 | 0.130 |
Why?
| | Anacardiaceae | 1 | 2017 | 4 | 0.130 |
Why?
| | Dermatitis, Atopic | 1 | 2020 | 321 | 0.130 |
Why?
| | Staphylococcus lugdunensis | 1 | 2016 | 2 | 0.130 |
Why?
| | Host-Pathogen Interactions | 2 | 2019 | 371 | 0.120 |
Why?
| | Influenza, Human | 1 | 2022 | 617 | 0.120 |
Why?
| | Cyclohexanones | 1 | 2016 | 9 | 0.120 |
Why?
| | Fagaceae | 1 | 2015 | 2 | 0.120 |
Why?
| | Mice, Inbred BALB C | 4 | 2022 | 1253 | 0.120 |
Why?
| | Oleanolic Acid | 1 | 2015 | 9 | 0.120 |
Why?
| | Signal Transduction | 4 | 2024 | 5233 | 0.120 |
Why?
| | Humans | 28 | 2026 | 144957 | 0.110 |
Why?
| | Oxyhemoglobins | 1 | 1995 | 28 | 0.110 |
Why?
| | Emodin | 1 | 2015 | 3 | 0.110 |
Why?
| | Skin Diseases | 1 | 2017 | 149 | 0.110 |
Why?
| | Microbiota | 2 | 2020 | 781 | 0.110 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2016 | 561 | 0.110 |
Why?
| | Rabbits | 4 | 2019 | 648 | 0.110 |
Why?
| | Anthraquinones | 1 | 2014 | 10 | 0.110 |
Why?
| | Animals | 14 | 2026 | 38109 | 0.110 |
Why?
| | Penicillium | 1 | 2014 | 8 | 0.110 |
Why?
| | Antibodies, Monoclonal | 1 | 2022 | 1524 | 0.110 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2014 | 179 | 0.100 |
Why?
| | Arginine | 1 | 1995 | 262 | 0.100 |
Why?
| | Hydrogen Bonding | 3 | 2005 | 169 | 0.100 |
Why?
| | Models, Genetic | 1 | 2016 | 536 | 0.100 |
Why?
| | Carbon Monoxide | 2 | 2005 | 82 | 0.100 |
Why?
| | Chromatography, High Pressure Liquid | 3 | 2013 | 598 | 0.100 |
Why?
| | Immunity, Innate | 1 | 2019 | 846 | 0.100 |
Why?
| | Oxygen | 4 | 2005 | 995 | 0.090 |
Why?
| | Hydrastis | 1 | 2012 | 3 | 0.090 |
Why?
| | Berberine | 1 | 2012 | 5 | 0.090 |
Why?
| | Protein Binding | 2 | 2011 | 2276 | 0.090 |
Why?
| | Protein Structure, Secondary | 1 | 1993 | 369 | 0.090 |
Why?
| | Interleukin-8 | 2 | 2024 | 271 | 0.090 |
Why?
| | Repressor Proteins | 1 | 2015 | 437 | 0.090 |
Why?
| | Cells, Cultured | 4 | 2021 | 4155 | 0.090 |
Why?
| | Chlorides | 1 | 1992 | 142 | 0.080 |
Why?
| | Conserved Sequence | 1 | 2011 | 245 | 0.080 |
Why?
| | Sequence Alignment | 1 | 2011 | 368 | 0.080 |
Why?
| | Kinetics | 3 | 2005 | 1629 | 0.080 |
Why?
| | Staphylococcus | 1 | 2010 | 75 | 0.080 |
Why?
| | Ethanol | 1 | 2015 | 627 | 0.080 |
Why?
| | Crystallization | 4 | 2004 | 146 | 0.080 |
Why?
| | X-Ray Diffraction | 4 | 1993 | 104 | 0.070 |
Why?
| | In Vitro Techniques | 2 | 2015 | 1048 | 0.070 |
Why?
| | Genes, Reporter | 1 | 2009 | 276 | 0.070 |
Why?
| | Recombinant Proteins | 3 | 2015 | 1371 | 0.070 |
Why?
| | Cathelicidins | 2 | 2020 | 41 | 0.070 |
Why?
| | Luminescent Proteins | 1 | 2009 | 185 | 0.070 |
Why?
| | Alcoholism | 1 | 2015 | 817 | 0.070 |
Why?
| | Toll-Like Receptor 2 | 2 | 2021 | 126 | 0.070 |
Why?
| | Antimicrobial Cationic Peptides | 2 | 2020 | 86 | 0.070 |
Why?
| | Molecular Structure | 3 | 2014 | 501 | 0.060 |
Why?
| | Metalloproteases | 1 | 2007 | 42 | 0.060 |
Why?
| | beta-Lactamases | 1 | 2007 | 51 | 0.060 |
Why?
| | Biological Assay | 1 | 2007 | 128 | 0.060 |
Why?
| | Keratinocytes | 2 | 2020 | 250 | 0.060 |
Why?
| | Thermodynamics | 2 | 2001 | 426 | 0.060 |
Why?
| | Substrate Specificity | 1 | 2007 | 392 | 0.060 |
Why?
| | Mice, Inbred C57BL | 4 | 2020 | 5997 | 0.060 |
Why?
| | Hemolysin Proteins | 2 | 2017 | 36 | 0.060 |
Why?
| | Ligands | 2 | 2005 | 674 | 0.060 |
Why?
| | Inhibitory Concentration 50 | 2 | 2016 | 91 | 0.060 |
Why?
| | Mutagenesis, Insertional | 1 | 2005 | 64 | 0.060 |
Why?
| | Allosteric Regulation | 1 | 2005 | 98 | 0.060 |
Why?
| | Spectrum Analysis, Raman | 1 | 2005 | 41 | 0.050 |
Why?
| | Disease Models, Animal | 3 | 2026 | 4569 | 0.050 |
Why?
| | Peptides | 1 | 2010 | 998 | 0.050 |
Why?
| | Dimerization | 1 | 2005 | 194 | 0.050 |
Why?
| | Solutions | 1 | 2005 | 167 | 0.050 |
Why?
| | Cross-Linking Reagents | 1 | 2005 | 207 | 0.050 |
Why?
| | Enzyme Inhibitors | 1 | 2007 | 826 | 0.050 |
Why?
| | Inflammation | 1 | 2015 | 2880 | 0.050 |
Why?
| | Cytotoxins | 1 | 2022 | 16 | 0.050 |
Why?
| | Cephalothin | 1 | 2022 | 5 | 0.050 |
Why?
| | Oxacillin | 1 | 2022 | 5 | 0.050 |
Why?
| | Methicillin | 1 | 2022 | 10 | 0.050 |
Why?
| | Cefadroxil | 1 | 2022 | 8 | 0.050 |
Why?
| | Cefazolin | 1 | 2022 | 22 | 0.050 |
Why?
| | Teichoic Acids | 1 | 2022 | 18 | 0.040 |
Why?
| | Macromolecular Substances | 2 | 1992 | 224 | 0.040 |
Why?
| | Toll-Like Receptor 1 | 1 | 2021 | 13 | 0.040 |
Why?
| | Lipoylation | 1 | 2021 | 17 | 0.040 |
Why?
| | Pancreatic Elastase | 1 | 2021 | 55 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2024 | 621 | 0.040 |
Why?
| | Photolysis | 1 | 2001 | 94 | 0.040 |
Why?
| | Catheter-Related Infections | 1 | 2022 | 94 | 0.040 |
Why?
| | Desmoglein 1 | 1 | 2020 | 2 | 0.040 |
Why?
| | Phosphorylation | 1 | 2024 | 1733 | 0.040 |
Why?
| | Valine | 3 | 1999 | 80 | 0.040 |
Why?
| | Nitric Oxide | 1 | 2004 | 897 | 0.040 |
Why?
| | Methionine | 3 | 1999 | 162 | 0.040 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2019 | 194 | 0.030 |
Why?
| | Reproducibility of Results | 2 | 2013 | 3415 | 0.030 |
Why?
| | Toxins, Biological | 1 | 2017 | 12 | 0.030 |
Why?
| | Soft Tissue Infections | 1 | 2017 | 39 | 0.030 |
Why?
| | Necrosis | 1 | 2017 | 244 | 0.030 |
Why?
| | Female | 5 | 2026 | 78376 | 0.030 |
Why?
| | Bacteria | 1 | 2022 | 889 | 0.030 |
Why?
| | Drug Discovery | 1 | 2016 | 155 | 0.030 |
Why?
| | Male | 5 | 2026 | 72406 | 0.030 |
Why?
| | Hypersensitivity, Delayed | 1 | 2015 | 29 | 0.030 |
Why?
| | Interleukin-23 | 1 | 2015 | 16 | 0.030 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2015 | 58 | 0.030 |
Why?
| | Osmolar Concentration | 1 | 1995 | 167 | 0.030 |
Why?
| | Bacterial Toxins | 1 | 2015 | 110 | 0.030 |
Why?
| | Bacterial Load | 1 | 2015 | 67 | 0.030 |
Why?
| | Neutrophil Infiltration | 1 | 2015 | 104 | 0.030 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 2015 | 100 | 0.030 |
Why?
| | Green Fluorescent Proteins | 1 | 2016 | 405 | 0.030 |
Why?
| | Sodium Chloride | 1 | 1995 | 142 | 0.030 |
Why?
| | Plant Leaves | 1 | 2015 | 137 | 0.030 |
Why?
| | Escherichia coli | 1 | 1999 | 855 | 0.030 |
Why?
| | Interleukin-17 | 1 | 2015 | 118 | 0.030 |
Why?
| | Peptide Hydrolases | 1 | 2015 | 105 | 0.030 |
Why?
| | Drug Resistance, Bacterial | 1 | 2015 | 199 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 1995 | 570 | 0.030 |
Why?
| | Alleles | 1 | 2017 | 881 | 0.030 |
Why?
| | Myeloid Cells | 1 | 2015 | 148 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2021 | 2147 | 0.030 |
Why?
| | Microarray Analysis | 1 | 2013 | 117 | 0.020 |
Why?
| | Immunocompromised Host | 1 | 2015 | 201 | 0.020 |
Why?
| | Leukocytes | 1 | 2015 | 295 | 0.020 |
Why?
| | Genes, Bacterial | 1 | 2013 | 166 | 0.020 |
Why?
| | Disease Susceptibility | 1 | 2015 | 348 | 0.020 |
Why?
| | Regulon | 1 | 2013 | 34 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2015 | 395 | 0.020 |
Why?
| | Plants, Medicinal | 1 | 2012 | 23 | 0.020 |
Why?
| | T-Lymphocyte Subsets | 1 | 2015 | 415 | 0.020 |
Why?
| | Microbial Viability | 1 | 2013 | 90 | 0.020 |
Why?
| | Chemistry, Physical | 1 | 1992 | 39 | 0.020 |
Why?
| | Peritonitis | 1 | 2013 | 84 | 0.020 |
Why?
| | Anions | 1 | 1992 | 31 | 0.020 |
Why?
| | Chemical Phenomena | 1 | 1992 | 81 | 0.020 |
Why?
| | Bacteremia | 1 | 2015 | 221 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2925 | 0.020 |
Why?
| | Lymph Nodes | 1 | 2015 | 502 | 0.020 |
Why?
| | Gene Deletion | 1 | 2013 | 389 | 0.020 |
Why?
| | Sigma Factor | 1 | 2011 | 43 | 0.020 |
Why?
| | Alanine | 1 | 1992 | 171 | 0.020 |
Why?
| | Hemolysis | 1 | 2013 | 243 | 0.020 |
Why?
| | RNA Polymerase III | 1 | 2010 | 34 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2015 | 1258 | 0.020 |
Why?
| | Stress, Physiological | 1 | 2013 | 453 | 0.020 |
Why?
| | Cell Line | 1 | 2015 | 2882 | 0.020 |
Why?
| | Erythrocytes | 1 | 2015 | 757 | 0.020 |
Why?
| | Lung | 1 | 2022 | 4109 | 0.020 |
Why?
| | Weight Loss | 1 | 2015 | 837 | 0.020 |
Why?
| | Plasmids | 1 | 2009 | 379 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2009 | 418 | 0.020 |
Why?
| | Cytokines | 1 | 2015 | 2065 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2013 | 1339 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2013 | 1786 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2009 | 1173 | 0.010 |
Why?
| | Transcription Factors | 1 | 2013 | 1742 | 0.010 |
Why?
| | Anaerobiosis | 1 | 2004 | 64 | 0.010 |
Why?
| | Histidine | 1 | 2004 | 66 | 0.010 |
Why?
| | Heme | 1 | 2004 | 89 | 0.010 |
Why?
| | Cysteine | 1 | 2004 | 210 | 0.010 |
Why?
| | Child | 1 | 2022 | 22657 | 0.010 |
Why?
| | Sulfhydryl Compounds | 1 | 2004 | 189 | 0.010 |
Why?
| | Iron | 1 | 2004 | 359 | 0.010 |
Why?
| | Hemoglobin M | 1 | 1999 | 2 | 0.010 |
Why?
| | Chemical Fractionation | 1 | 1999 | 28 | 0.010 |
Why?
| | Peptide Fragments | 1 | 1999 | 699 | 0.010 |
Why?
| | Computer Simulation | 1 | 1997 | 1026 | 0.010 |
Why?
| | Glutamates | 1 | 1992 | 66 | 0.010 |
Why?
| | Acetylation | 1 | 1992 | 256 | 0.010 |
Why?
| | Aged | 1 | 1992 | 25947 | 0.000 |
Why?
|
|
Kavanaugh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|